<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">23166855</PMID>
      <DateCompleted>
        <Year>2013</Year>
        <Month>04</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1935-2735</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>6</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2012</Year>
            </PubDate>
          </JournalIssue>
          <Title>PLoS neglected tropical diseases</Title>
          <ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Salmonella typhi in the democratic republic of the congo: fluoroquinolone decreased susceptibility on the rise.</ArticleTitle>
        <Pagination>
          <StartPage>e1921</StartPage>
          <MedlinePgn>e1921</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e1921</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0001921</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Drug resistance of Salmonella enterica serovar Typhi (Salmonella Typhi) to first-line antibiotics is emerging in Central Africa. Although increased use of fluoroquinolones is associated with spread of resistance, Salmonella Typhi with decreased ciprofloxacin susceptibility (DCS) has rarely been reported in Central Africa.</AbstractText>
          <AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">As part of a microbiological surveillance study in the Democratic Republic of the Congo (DR Congo), Salmonella Typhi isolates from bloodstream infections were collected prospectively between 2007 and 2011. The genetic relationship of the Salmonella Typhi isolates was assessed by pulsed-field gel electrophoresis (PFGE). The antimicrobial resistance profile of the isolates was determined and mutations associated with DCS were studied. In total, 201 Salmonella Typhi isolates were collected. More than half of the Salmonella Typhi isolates originated from children and young adults aged 5-19. Thirty different PFGE profiles were identified, with 72% of the isolates showing a single profile. Multidrug resistance, DCS and azithromycin resistance were 30.3%, 15.4% and 1.0%, respectively. DCS was associated with point mutations in the gyrA gene at codons 83 and 87.</AbstractText>
          <AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">Our study describes the first report of widespread multidrug resistance and DCS among Salmonella Typhi isolates from DR Congo. Our findings highlight the need for increased microbiological diagnosis and surveillance in DR Congo, being a prerequisite for rational use of antimicrobials and the development of standard treatment guidelines.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lunguya</LastName>
            <ForeName>Octavie</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lejon</LastName>
            <ForeName>Veerle</ForeName>
            <Initials>V</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Phoba</LastName>
            <ForeName>Marie-France</ForeName>
            <Initials>MF</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bertrand</LastName>
            <ForeName>Sophie</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vanhoof</LastName>
            <ForeName>Raymond</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verhaegen</LastName>
            <ForeName>Jan</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Anthony Marius</ForeName>
            <Initials>AM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Keddy</LastName>
            <ForeName>Karen Helena</ForeName>
            <Initials>KH</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muyembe-Tamfum</LastName>
            <ForeName>Jean-Jacques</ForeName>
            <Initials>JJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jacobs</LastName>
            <ForeName>Jan</ForeName>
            <Initials>J</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2012</Year>
          <Month>11</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS Negl Trop Dis</MedlineTA>
        <NlmUniqueID>101291488</NlmUniqueID>
        <ISSNLinking>1935-2727</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D024841">Fluoroquinolones</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001769" MajorTopicYN="N">Blood</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015023" MajorTopicYN="N" Type="Geographic">Democratic Republic of the Congo</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024901" MajorTopicYN="Y">Drug Resistance, Multiple, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016521" MajorTopicYN="N">Electrophoresis, Gel, Pulsed-Field</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024841" MajorTopicYN="N">Fluoroquinolones</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058889" MajorTopicYN="N">Molecular Typing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012485" MajorTopicYN="N">Salmonella typhi</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014435" MajorTopicYN="N">Typhoid Fever</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2012</Year>
          <Month>6</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2012</Year>
          <Month>10</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2012</Year>
          <Month>11</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2012</Year>
          <Month>11</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2013</Year>
          <Month>4</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23166855</ArticleId>
        <ArticleId IdType="pmc">PMC3499407</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.pntd.0001921</ArticleId>
        <ArticleId IdType="pii">PNTD-D-12-00769</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Vlieghe E, Phoba MF, Tamfun JJ, Jacobs J (2009) Antibiotic resistance among bacterial pathogens in Central Africa: a review of the published literature between 1955 and 2008. Int J Antimicrob Agents
34: 295–303 S0924-8579(09)00217-9 [pii];10.1016/j.ijantimicag.2009.04.015 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19540725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vandenberg O, Nyarukweba DZ, Ndeba PM, Hendriksen RS, Barzilay EJ, et al. (2010) Microbiologic and clinical features of Salmonella species isolated from bacteremic children in eastern Democratic Republic of Congo. Pediatr Infect Dis J
29: 504–510 10.1097/INF.0b013e3181cd615a [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20104200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Muyembe-Tamfum JJ, Veyi J, Kaswa M, Lunguya O, Verhaegen J, et al. (2009) An outbreak of peritonitis caused by multidrug-resistant Salmonella Typhi in Kinshasa, Democratic Republic of Congo. Travel Med Infect Dis
7: 40–43 S1477-8939(08)00156-7 [pii];10.1016/j.tmaid.2008.12.006 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19174300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Crump JA, Mintz ED (2010) Global trends in typhoid and paratyphoid Fever. Clin Infect Dis
50: 241–246 10.1086/649541 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2798017</ArticleId>
            <ArticleId IdType="pubmed">20014951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lutterloh E, Likaka A, Sejvar J, Manda R, Naiene J, et al. (2012) Multidrug-resistant typhoid Fever with neurologic findings on the Malawi-mozambique border. Clin Infect Dis
54: 1100–1106 cis012 [pii];10.1093/cid/cis012 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22357702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kariuki S, Revathi G, Muyodi J, Mwituria J, Munyalo A, et al. (2004) Characterization of multidrug-resistant typhoid outbreaks in Kenya. J Clin Microbiol
42: 1477–1482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC387605</ArticleId>
            <ArticleId IdType="pubmed">15070992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Smith AM, Govender N, Keddy KH (2010) Quinolone-resistant Salmonella Typhi in South Africa, 2003–2007. Epidemiol Infect
138: 86–90 S0950268809990331 [pii];10.1017/S0950268809990331 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19563699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nkemngu NJ, Asonganyi ED, Njunda AL (2005) Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon. BMC Infect Dis
5: 49 1471-2334-5-49 [pii];10.1186/1471-2334-5-49 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1184073</ArticleId>
            <ArticleId IdType="pubmed">15969764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Neil KP, Sodha SV, Lukwago L, Tipo S, Mikoleit M, et al. (2012) A large outbreak of typhoid Fever associated with a high rate of intestinal perforation in kasese district, Uganda, 2008–2009. Clin Infect Dis
54: 1091–1099 cis025 [pii];10.1093/cid/cis025 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22357703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lunguya O, Phoba MF, Mundeke SABE, Mukadi P, Muyembe-Tamfum JJ, et al. (2012) The diagnosis of typhoid fever in the Democratic Republic of the Congo. Transactions of the Royal Society of Tropical Medicine and Hygiene
106: 348–355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22551639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia LS, Isenberg HD (2007) Clinical Microbiology Procedures Handbook. Washington: ASM Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Grimont PAD, Weill FX (2007) Antigenic formulae of the Salmonella Serovars. Paris: World Health Organization, Institut Pasteur. 166 p.</Citation>
        </Reference>
        <Reference>
          <Citation>CLSI (2012) Performance standards for antimicrobial susceptibility testing; Twenty-second informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute. 188 p.</Citation>
        </Reference>
        <Reference>
          <Citation>
EUCAST (2012) Breakpoint tables for interpretation of MICs and zone diameters. Version 2.0. Version 2.0
1–73.</Citation>
        </Reference>
        <Reference>
          <Citation>
Cavaco LM, Frimodt-Moller N, Hasman H, Guardabassi L, Nielsen L, et al. (2008) Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark. Microb Drug Resist
14: 163–169 10.1089/mdr.2008.0821 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18500921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, et al. (2006) Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis
3: 59–67 10.1089/fpd.2006.3.59 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16602980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bakker HC, Switt AI, Cummings CA, Hoelzer K, Degoricija L, et al. (2011) A whole-genome single nucleotide polymorphism-based approach to trace and identify outbreaks linked to a common Salmonella enterica subsp. enterica serovar Montevideo pulsed-field gel electrophoresis type. Appl Environ Microbiol
77: 8648–8655 AEM.06538-11 [pii];10.1128/AEM.06538-11 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3233099</ArticleId>
            <ArticleId IdType="pubmed">22003026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Crump JA, Luby SP, Mintz ED (2004) The global burden of typhoid fever. Bull World Health Organ
82: 346–353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2622843</ArticleId>
            <ArticleId IdType="pubmed">15298225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Feasey NA, Archer BN, Heyderman RS, Sooka A, Dennis B, et al. (2010) Typhoid fever and invasive nontyphoid salmonellosis, Malawi and South Africa. Emerg Infect Dis
16: 1448–1451 10.3201/eid1609.100125 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3294972</ArticleId>
            <ArticleId IdType="pubmed">20735930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bhutta ZA (2006) Current concepts in the diagnosis and treatment of typhoid fever. BMJ
333: 78–82 333/7558/78 [pii];10.1136/bmj.333.7558.78 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1489205</ArticleId>
            <ArticleId IdType="pubmed">16825230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Breiman RF, Cosmas L, Njuguna H, Audi A, Olack B, et al. (2012) Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS One
7: e29119 10.1371/journal.pone.0029119 [doi];PONE-D-11-14547 [pii].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3261857</ArticleId>
            <ArticleId IdType="pubmed">22276105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Akinyemi KO, Bamiro BS, Coker AO (2007) Salmonellosis in Lagos, Nigeria: incidence of Plasmodium falciparum-associated co-infection, patterns of antimicrobial resistance, and emergence of reduced susceptibility to fluoroquinolones. J Health Popul Nutr
25: 351–358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2754035</ArticleId>
            <ArticleId IdType="pubmed">18330069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tien YY, Ushijima H, Mizuguchi M, Liang SY, Chiou CS (2012) Use of multilocus variable-number tandem repeat analysis in molecular subtyping of Salmonella enterica serovar Typhi isolates. J Med Microbiol
61: 223–232 jmm.0.037291-0 [pii];10.1099/jmm.0.037291-0 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21997873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Parry CM, Vinh H, Chinh NT, Wain J, Campbell JI, et al. (2011) The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy. PLoS Negl Trop Dis
5: e1163 10.1371/journal.pntd.0001163 [doi];PNTD-D-10-00171 [pii].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3119645</ArticleId>
            <ArticleId IdType="pubmed">21713025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Parry CM, Thuy CT, Dongol S, Karkey A, Vinh H, et al. (2010) Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones. Antimicrob Agents Chemother
54: 5201–5208 AAC.00963-10 [pii];10.1128/AAC.00963-10 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2981260</ArticleId>
            <ArticleId IdType="pubmed">20837759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
De Boeck H, Miwanda B, Lunguya-Metila O, Muyembe-Tamfum JJ, Stobberingh E, et al. (2012) ESBL-positive enterobacteria isolates in drinking water. Emerg Infect Dis
18 Serial on the Internet.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3358152</ArticleId>
            <ArticleId IdType="pubmed">22608263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Crump JA (2012) Typhoid Fever and the challenge of nonmalaria febrile illness in sub-saharan Africa. Clin Infect Dis
54: 1107–1109 cis024 [pii];10.1093/cid/cis024 [doi].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22357701</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
